Novartis enhances its focus with eyecare deal
Wednesday, May 21, 2014 - 10:30
in Mathematics & Economics
Swiss firm buys rights to wet AMD drug from Ophthotech for up to $1bn
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via